Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch
  

Kalobios Pharmaceuticals Inc patents

Recent patent applications related to Kalobios Pharmaceuticals Inc. Kalobios Pharmaceuticals Inc is listed as an Agent/Assignee. Note: Kalobios Pharmaceuticals Inc may have other listings under different names/spellings. We're not affiliated with Kalobios Pharmaceuticals Inc, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "K" | Kalobios Pharmaceuticals Inc-related inventors




Date Kalobios Pharmaceuticals Inc patents (updated weekly) - BOOKMARK this page
08/10/17Treatment of leukemias and chronic myeloproliferative diseases with antibodies to epha3
04/14/16Immunoglobulin variable region cassette exchange
12/03/15Antibodies to granulocyte-macrophage colony-stimulating factor
11/19/15Methods of treating hematological proliferative disorders by targeting epha3 expressed on aberrant vasculature in bone marrow
09/03/15Methods of treating chronic inflammatory diseases using a gm-csf antagonist
01/29/15Antibodies to the pcrv antigen of pseudomonas aeruginosa
12/18/14Treatment of leukemias and chronic myeloproliferative diseases with antibodies to epha3
05/01/14Antibodies to epha3
06/20/13Methods of treating dementia using a gm-csf antagonist
05/02/13Generation of antibodies to an epitope of interest that contains a phosphomimetic amino acid
02/14/13Methods of treating hematological proliferative disorders by targeting epha3 expressed on aberrant vasculature in bone marrow
12/06/12Secretion of antibodies without signal peptides from bacteria
08/23/12Antibodies to granulocyte-macrophage colony-stimulating factor
01/26/12Antibodies to the pcrv antigen of pseudomonas aeruginosa
01/12/12Methods of treating bone-loss disorders using a gm-csf antagonist
10/06/11Epha3 antibodies for the treatment of multiple myeloma
10/06/11Generation of antibodies to an epitope of interest
07/07/11Method of treating a staphylococcus infection in a patient having a low-level pathogenic pseudomonas aeruginosa infection
05/26/11Antibodies to epha3
09/09/10Treatment of leukemias and chronic myeloproliferative diseases with antibodies to epha3
08/26/10Methods of treating dementia using a gm-csf antagonist
11/05/09Antibodies to granulocyte-macrophage colony-stimulating factor
10/22/09Neutralization of gm-csf for the treatment of heart failure
07/30/09Antibodies to the pcrv antigen of pseudomonas aeruginosa
07/16/09Methods of treating bone-loss disorders using a gm-csf antagonist







ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Kalobios Pharmaceuticals Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Kalobios Pharmaceuticals Inc with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';